Vanguard disaggregates holdings; reports 0% stake in Zoetis (ZTS)
Rhea-AI Filing Summary
Zoetis Inc. Schedule 13G/A amendment shows The Vanguard Group reports no beneficial ownership of Zoetis common stock. The filing, labeled Amendment No. 11, explains an internal realignment effective January 12, 2026 that led certain Vanguard subsidiaries to report holdings separately. The filing states 0 shares beneficially owned and 0% of the class, and is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026. The issuer address is listed as 10 Sylvan Way, Parsippany, NJ.
Positive
- None.
Negative
- None.
Insights
Vanguard's internal realignment produced separate reporting; Zoetis stake is reported as zero.
The filing documents that, following the January 12, 2026 realignment, certain Vanguard subsidiaries now report disaggregated positions under SEC Release No. 34-39538. The Schedule 13G/A shows 0% beneficial ownership and zero voting and dispositive power.
Practical implication: holdings previously attributed to The Vanguard Group may now appear under subsidiary filings. Subsequent filings from Vanguard entities should be checked for any nonzero positions attributed to those subsidiaries.
Amendment cites SEC release and clarifies beneficial ownership attribution after reorganization.
The submission relies on SEC Release No. 34-39538 to justify separate reporting by subsidiaries; it affirms that The Vanguard Group "no longer has, or is deemed to have, beneficial ownership" of securities held by those units. The filing records 0 shares and 0% of the class.
Compliance note: this is a disclosure adjustment tied to internal structure. Review related 13G/A or 13D filings from Vanguard affiliates for any transferred beneficial positions to understand aggregate institutional exposure.
FAQ
Does The Vanguard Group own any Zoetis (ZTS) shares after this amendment?
Why does Vanguard say subsidiaries will report separately for ZTS?
Who signed the Schedule 13G/A amendment for Vanguard on Zoetis?
Should investors expect a change in reported institutional holdings for ZTS?
What voting or dispositive power does Vanguard report for ZTS here?